{
  "DOI": "10.1038/sj.ejhg.5201791",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/sj.ejhg.5201791",
  "alternative-id": [
    "BF5201791"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Zimmermann",
      "given": "Nicole",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Acosta",
      "given": "Ana Maria Bravo Ferrer",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kohlhase",
      "given": "Jürgen",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bartsch",
      "given": "Oliver",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2007,
        2,
        14
      ]
    ],
    "date-time": "2007-02-14T05:19:12Z",
    "timestamp": 1171430352000
  },
  "deposited": {
    "date-parts": [
      [
        2024,
        2,
        10
      ]
    ],
    "date-time": "2024-02-10T23:06:00Z",
    "timestamp": 1707606360000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        2
      ]
    ],
    "date-time": "2024-03-02T09:30:26Z",
    "timestamp": 1709371826338
  },
  "is-referenced-by-count": 70,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "8",
  "issued": {
    "date-parts": [
      [
        2007,
        2,
        14
      ]
    ]
  },
  "journal-issue": {
    "issue": "8",
    "published-print": {
      "date-parts": [
        [
          2007,
          8
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2007,
            2,
            14
          ]
        ],
        "date-time": "2007-02-14T00:00:00Z",
        "timestamp": 1171411200000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/5201791.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/5201791",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/5201791.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "837-842",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2007,
        2,
        14
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2007,
        2,
        14
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2007,
        8
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1038/376348a0",
      "author": "F Petrij",
      "doi-asserted-by": "publisher",
      "first-page": "348",
      "journal-title": "Nature",
      "key": "BF5201791_CR1",
      "unstructured": "Petrij F, Giles RH, Dauwerse HG et al: Rubinstein–Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 1995; 376: 348–351.",
      "volume": "376",
      "year": "1995"
    },
    {
      "DOI": "10.1136/jmg.39.6.415",
      "author": "I Coupry",
      "doi-asserted-by": "publisher",
      "first-page": "415",
      "journal-title": "J Med Genet",
      "key": "BF5201791_CR2",
      "unstructured": "Coupry I, Roudaut C, Stef M et al: Molecular analysis of the CBP gene in 60 patients with Rubinstein–Taybi syndrome. J Med Genet 2002; 39: 415–421.",
      "volume": "39",
      "year": "2002"
    },
    {
      "DOI": "10.1007/s00439-005-1331-y",
      "author": "O Bartsch",
      "doi-asserted-by": "publisher",
      "first-page": "485",
      "journal-title": "Hum Genet",
      "key": "BF5201791_CR3",
      "unstructured": "Bartsch O, Schmidt S, Richter M et al: DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein–Taybi syndrome (RSTS) and in another patient with incomplete RSTS. Hum Genet 2005; 117: 485–493.",
      "volume": "117",
      "year": "2005"
    },
    {
      "DOI": "10.1086/429130",
      "author": "JH Roelfsema",
      "doi-asserted-by": "publisher",
      "first-page": "572",
      "journal-title": "Am J Hum Genet",
      "key": "BF5201791_CR4",
      "unstructured": "Roelfsema JH, White SJ, Ariyurek Y et al: Genetic heterogeneity in Rubinstein–Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am J Hum Genet 2005; 76: 572–580.",
      "volume": "76",
      "year": "2005"
    },
    {
      "DOI": "10.1093/hmg/10.10.1071",
      "author": "T Murata",
      "doi-asserted-by": "publisher",
      "first-page": "1071",
      "journal-title": "Hum Mol Genet",
      "key": "BF5201791_CR5",
      "unstructured": "Murata T, Kurokawa R, Krones A et al: Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein–Taybi syndrome. Hum Mol Genet 2001; 10: 1071–1076.",
      "volume": "10",
      "year": "2001"
    },
    {
      "DOI": "10.1093/hmg/ddg039",
      "author": "E Kalkhoven",
      "doi-asserted-by": "publisher",
      "first-page": "441",
      "journal-title": "Hum Mol Genet",
      "key": "BF5201791_CR6",
      "unstructured": "Kalkhoven E, Roelfsema JH, Teunissen H et al: Loss of CBP acetyltransferase activity by PHD finger mutations in Rubinstein–Taybi syndrome. Hum Mol Genet 2003; 12: 441–450.",
      "volume": "12",
      "year": "2003"
    },
    {
      "DOI": "10.1016/S0168-9525(98)01438-3",
      "author": "RH Giles",
      "doi-asserted-by": "publisher",
      "first-page": "178",
      "journal-title": "Trends Genet",
      "key": "BF5201791_CR7",
      "unstructured": "Giles RH, Peters DJ, Breuning MH : Conjunction dysfunction: CBP/p300 in human disease. Trends Genet 1998; 14: 178–183.",
      "volume": "14",
      "year": "1998"
    },
    {
      "DOI": "10.1016/S0092-8674(00)81165-4",
      "author": "TP Yao",
      "doi-asserted-by": "publisher",
      "first-page": "361",
      "journal-title": "Cell",
      "key": "BF5201791_CR8",
      "unstructured": "Yao TP, Oh SP, Fuchs M et al: Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 1998; 93: 361–372.",
      "volume": "93",
      "year": "1998"
    },
    {
      "author": "A Partanen",
      "first-page": "487",
      "journal-title": "Int J Dev Biol",
      "key": "BF5201791_CR9",
      "unstructured": "Partanen A, Motoyama J, Hui CC : Developmentally regulated expression of the transcriptional cofactors/histone acetyltransferases CBP and p300 during mouse embryogenesis. Int J Dev Biol 1999; 43: 487–494.",
      "volume": "43",
      "year": "1999"
    },
    {
      "DOI": "10.1101/gad.14.13.1553",
      "author": "RH Goodman",
      "doi-asserted-by": "crossref",
      "first-page": "1553",
      "journal-title": "Genes Dev",
      "key": "BF5201791_CR10",
      "unstructured": "Goodman RH, Smolik S : CBP/p300 in cell growth, transformation, and development. Genes Dev 2000; 14: 1553–1578.",
      "volume": "14",
      "year": "2000"
    },
    {
      "DOI": "10.1093/emboj/cdg473",
      "author": "JF Roth",
      "doi-asserted-by": "publisher",
      "first-page": "5186",
      "journal-title": "EMBO J",
      "key": "BF5201791_CR11",
      "unstructured": "Roth JF, Shikama N, Henzen C et al: Differential role of p300 and CBP acetyltransferase during myogenesis: p300 acts upstream of MyoD and Myf5. EMBO J 2003; 22: 5186–5196.",
      "volume": "22",
      "year": "2003"
    },
    {
      "DOI": "10.1016/j.bcp.2004.03.045",
      "author": "E Kalkhoven",
      "doi-asserted-by": "publisher",
      "first-page": "1145",
      "journal-title": "Biochem Pharmacol",
      "key": "BF5201791_CR12",
      "unstructured": "Kalkhoven E : CBP and p300: HATs for different occasions. Biochem Pharmacol 2004; 68: 1145–1155.",
      "volume": "68",
      "year": "2004"
    },
    {
      "DOI": "10.1136/jmg.2004.019901",
      "author": "W Borozdin",
      "doi-asserted-by": "publisher",
      "first-page": "e113",
      "journal-title": "J Med Genet",
      "key": "BF5201791_CR13",
      "unstructured": "Borozdin W, Boehm D, Leipoldt M et al: SALL4 deletions are a common cause of Okihiro and acro-renal-ocular syndromes and confirm haploinsufficiency as the pathogenetic mechanism. J Med Genet 2004; 41: e113.",
      "volume": "41",
      "year": "2004"
    },
    {
      "DOI": "10.1002/humu.20001",
      "author": "I Coupry",
      "doi-asserted-by": "publisher",
      "first-page": "278",
      "journal-title": "Hum Mutat",
      "key": "BF5201791_CR14",
      "unstructured": "Coupry I, Monnet L, Attia AA, Taine L, Lacombe D, Arveiler B : Analysis of CBP CREBBP) gene deletions in Rubinstein–Taybi syndrome patients using real-time quantitative PCR. Hum Mutat 2004; 23: 278–284.",
      "volume": "23",
      "year": "2004"
    },
    {
      "DOI": "10.1136/jmg.39.7.496",
      "author": "O Bartsch",
      "doi-asserted-by": "publisher",
      "first-page": "496",
      "journal-title": "J Med Genet",
      "key": "BF5201791_CR15",
      "unstructured": "Bartsch O, Locher K, Meinecke P et al: Molecular studies in 10 cases of Rubinstein–Taybi syndrome, including a mild variant showing a missense mutation in codon 1175 of CREBBP. J Med Genet 2002; 39: 496–501.",
      "volume": "39",
      "year": "2002"
    },
    {
      "DOI": "10.1007/s001099900021",
      "author": "H Ugai",
      "doi-asserted-by": "publisher",
      "first-page": "481",
      "journal-title": "J Mol Med",
      "key": "BF5201791_CR16",
      "unstructured": "Ugai H, Uchida K, Kawasaki H, Yokoyama KK : The coactivators p300 and CBP have different functions during the differentiation of F9 cells. J Mol Med 1999; 77: 481–494.",
      "volume": "77",
      "year": "1999"
    },
    {
      "DOI": "10.1038/sj.ejhg.5201594",
      "author": "RCM Hennekam",
      "doi-asserted-by": "publisher",
      "first-page": "981",
      "journal-title": "Eur J Hum Genet",
      "key": "BF5201791_CR17",
      "unstructured": "Hennekam RCM : Rubinstein–Taybi syndrome. Eur J Hum Genet 2006; 14: 981–985.",
      "volume": "14",
      "year": "2006"
    },
    {
      "DOI": "10.1038/30538",
      "author": "H Kawasaki",
      "doi-asserted-by": "publisher",
      "first-page": "285",
      "journal-title": "Nature",
      "key": "BF5201791_CR18",
      "unstructured": "Kawasaki H, Eckner R, Yao TP et al: Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation. Nature 1998; 393: 285–289.",
      "volume": "393",
      "year": "1998"
    }
  ],
  "reference-count": 18,
  "references-count": 18,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/5201791"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Confirmation of EP300 gene mutations as a rare cause of Rubinstein–Taybi syndrome"
  ],
  "type": "journal-article",
  "volume": "15"
}